Home / Pages / Speakers

Pages

Speakers

print
 

Mara Aspinall
President & Chief Executive Officer, On-Q-ity
 
Anna Barker, Ph.D.
Deputy Director, Strategic Scientific Initiatives, NIH
 
Jane Barlow
Vice President, Medical Strategy & Clinical Quality, Medco
 
Mark Boguski, M.D., Ph.D.
Department of Pathology, Beth Israel Deaconess Medical Center
 
Michael Bristow, M.D., Ph.D.
Chief Executive Officer, ARCA biopharma
 
William Chin, M.D.
Executive Dean for Research, Harvard Medical School

Neil de Crescenzo
Senior Vice President and General Manager, Oracle Health Sciences Global Business Unit

Mikael Dolsten, M.D., Ph.D.
President, Pfizer Worldwide Research & Development

Jennifer Gordon
Partner, Baker Botts LLP

William Hagstrom
Chief Executive Officer, Crescendo Bioscience
 
Richard Hamermesh, D.B.A.
MBA Class of 1961 Professor of Management Practice, Harvard Business School
 
Christopher Hansen, Esq.
Senior National Staff Counsel, American Civil Liberties Union
 
Anthony Hess, Ph.D.
Senior Vice President & General Manager, Health Solutions, SAIC

David Hickey
Executive Vice President, Central Laboratory & Global Research & Development, Siemens Healthcare Diagnostics
 
Peter Hirth, Ph.D.
Chief Executive Officer, Plexxikon
 
Katherine Holland
General Manager, Global Life Sciences Industry, IBM
 
Carolyn Johnson
Science Writer, The Boston Globe

Raju Kucherlapati, Ph.D.
Professor of Genetics, Professor of Medicine, Harvard Medical School
 
Lawrence Lesko, Ph.D.
Director of Clinical Pharmacology, CDER, FDA

Harlan Levine, M.D.
Principal, Towers Watson
 
Sharon Levine
Associate Executive Director, Permanente Medical Group
 
Clay Marsh, M.D.
Professor, Senior Associate Vice President for Health Sciences Research, Ohio State University
 
Hugh Martin,
Chief Executive Officer, Pacific Biosciences
 
Christopher-Paul Milne, D.V.M., M.P.H., J.D.
Associate Director, Tufts Center for the Study of Drug Development

Arnold Milstein, M.D., M.P.H.
Chief Physician and US Thought Leader, Mercer Health & Benefits
 
Elizabeth Nabel, M.D.
President, Brigham and Women’s Hospital, Faulkner Hospital
 
Ryan Phelan
President, DNA Direct
 
Emad Rizk
President, McKesson Health Solutions

Sue Siegel
Partner, MDV-Mohr Davidow Ventures
 
Mark Stevenson
President & Chief Operating Officer, Life Technologies
 
Guillerme Suarez-Kurtz, M.D., Ph.D.
Head of Pharmacology, Brazilian National Cancer Institute, Coordinator, Brazilian National Pharmacogenomics Network (REFARGEN)
 
Charles Swanton, Ph.D.
Head, Translational Cancer Therapeutics, London branch, Cancer Research UK

Scott Weiss, M.D., M.S.
Scientific Director, Partners Center for Personalized Genetic Medicine, Professor of Medicine, Harvard Medical School

Back to top



View All





About PCPGM Overview | Programs | Speakers | Sponsors | Committee | Travel | Highlights | Blog | Register Online | Contact Us | Site Map
2010 © Partners HealthCare | Privacy Policy